N/A
N=20
Decreasing Alzheimer's Risk Through oNline Choreographed Exercise - Down Syndrome
Down Syndrome · Physical Inactivity
Bottom Line
View on ClinicalTrials.gov: NCT06537648 ↗Enrolled (actual)
20
Serious AEs
0.0%
Results posted
Mar 2026
Primary outcome: Primary: Attendance — 21.7 Number of Classes Attended
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Decreasing Alzheimer's Risk Through oNline Choreographed Exercise - Down Syndrome Program (Behavioral)
- Age
- Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Kansas Medical Center
- Primary completion
- May 2025
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Attendance |
21.7 | — |
| PRIMARY Retention |
20 | — |
| PRIMARY Adverse Events |
3; 1 | — |
| SECONDARY Energy Expenditure |
4.8 | — |
| SECONDARY Exercise Intensity |
90.1 | — |
Summary
The investigators are assessing acceptability, appropriateness, and feasibility of an remote choreographed exercise intervention using validated scales alongside qualitative data among young adults with Down Syndrome. Participants will take part in a 12-week exercise program with two 35-minute session per week delivered in a group setting. The aims of the project are to:
* Assess the feasibility of a 12 week remotely delivered group dance intervention.
* Assess changes in aerobic fitness and cognitive function in response to a 12 week remotely delivered group dance intervention.
* Assess the intensity and total energy expenditure of remotely delivered group dance sessions.
Eligibility Criteria
Inclusion Criteria
- Diagnosis of Down syndrome
- Sufficient functional ability to communicate through spoken language
- No plans to relocate outside the study area over the next 12 weeks
- Possession of a personal device that allows for connectivity to the internet and participate in 2x weekly group video calls
- Ability to participate in Moderate to vigorous physical activity
Exclusion Criteria
- Serious medical risk (e.g., cancer, recent heart attack, stroke, pregnancy, angioplasty as determined by the research staff
- unwilling to participate in outcomes assessments
- uninterested
Data sourced from ClinicalTrials.gov (NCT06537648). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.